Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima

ConclusionLow-dose MTX may be a key means of promoting early cell coverage via the inhibition of the inflammatory response and stability of neointima by targeting inflammatory pathways after stent implantation.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research